United States · FDA National Drug Code directory
Voraxaze
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50633-210_27e39e9a-42e0-fb03-e063-6394a90aae3e
- Product NDC
- 50633-210
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- glucarpidase
- Labeler
- BTG International Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20120401
- Source listing expiry
- 20261231
Source-listed ingredients
- GLUCARPIDASE — 1000 [USP'U]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (50633-210-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL · 50633-210-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →